BiomX (PHGE) Assets Average (2019 - 2026)
BiomX (PHGE) posted Assets Average of $4.5 million for Q1 2026, down 71.73% sequentially from $16.0 million in Q4 2025, and down 89.84% YoY from $44.4 million in Q1 2025.
BiomX (PHGE) Assets Average (2019 - 2026) Analysis & Trends
BiomX has reported Assets Average for 8 years, with the latest figure at $4.5 million in Q1 2026.
- Quarterly Assets Average fell 89.84% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 89.84% YoY) and the FY2025 annual result came in at $24.5 million, down 28.19% from the prior year.
- Assets Average slipped to $4.5 million in Q1 2026 per PHGE's latest filing, from $16.0 million in the prior quarter.
- Over five years, Assets Average peaked at $73.4 million in Q1 2022 and troughed at $4.5 million in Q1 2026.
- A 5-year average of $42.5 million and a median of $43.5 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2026: Assets Average soared 77.69% in 2024, then plunged 89.84% in 2026.
- Over 5 years, Assets Average stood at $48.7 million in 2022, then tumbled by 40.38% to $29.0 million in 2023, then jumped by 77.69% to $51.6 million in 2024, then tumbled by 69.04% to $16.0 million in 2025, then tumbled by 71.73% to $4.5 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $4.5 million, $16.0 million, and $32.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | 4.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 15.98 Mn |
| Sep 30, 2025 | 32.11 Mn |
| Jun 30, 2025 | 41.85 Mn |
| Mar 31, 2025 | 44.44 Mn |
| Dec 31, 2024 | 51.61 Mn |
| Sep 30, 2024 | 64.30 Mn |
| Jun 30, 2024 | 49.28 Mn |
| Mar 15, 2024 | 27.48 Mn |
| Dec 31, 2023 | 29.04 Mn |
| Sep 30, 2023 | 37.15 Mn |
| Jun 30, 2023 | 41.33 Mn |
| Mar 31, 2023 | 43.47 Mn |
| Dec 31, 2022 | 48.72 Mn |
| Sep 30, 2022 | 55.14 Mn |
| Jun 30, 2022 | 63.56 Mn |
| Mar 31, 2022 | 73.37 Mn |
| Dec 31, 2021 | 79.89 Mn |
| Sep 30, 2021 | 71.72 Mn |
| Jun 30, 2021 | 64.36 Mn |